A Case of Pembrolizumab-Induced Diabetic Ketoacidosis and Hyperthyroidism in a Patient With Recurrent Esophageal Adenocarcinoma

Immune checkpoint inhibitors (ICI) such as program cell death protein 1 (PD-1) inhibitors are widely used for the treatment of patients with recurrent, locally advanced or metastatic, gastric or gastroesophageal (GE) junction adenocarcinoma. Immune-related adverse events (irAE) such as endocrinopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Salangsang, Jonathan, Sapkota, Surendra, Kharel, Sanjeev, Gupta, Prakash, Kalla, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943615/
https://www.ncbi.nlm.nih.gov/pubmed/36825072
http://dx.doi.org/10.7759/cureus.35276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943615/
https://www.ncbi.nlm.nih.gov/pubmed/36825072
http://dx.doi.org/10.7759/cureus.35276

Ejemplares similares